Immune Pharmaceuticals Merges With EpiCept

Immune Pharmaceuticals Merges with EpiCept

Filed under: drug treatment news

Immune Pharmaceuticals and EpiCept have agreed to merge. The combined company, to be named Immune Pharmaceuticals, will be primarily focused on developing antibody therapeutics and other targeted drugs for the treatment of inflammatory diseases …
Read more on Genetic Engineering News

NDA Accepted for Suvorexant, a Novel Treatment for Insomnia

Filed under: drug treatment news

NDA Accepted for Suvorexant, a Novel Treatment for Insomnia. Merck announced that the New Drug Application (NDA) for suvorexant, the company's investigational insomnia medicine, has been accepted for standard review by the FDA. Suvorexant targets …
Read more on Monthly Prescribing Reference

Cipla slashes cancer drug prices by 64%

Filed under: drug treatment news

The drugs are used for treating lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers, it added. The lung cancer drug Erlocip will now cost Rs 9,900 for thirty tablets against its earlier …
Read more on Daily News & Analysis